Jenkem Technology Co., Ltd. (SHA:688356)

Market Cap	5.98B +72.8%
Revenue (ttm)	318.22M +40.1%
Net Income	61.70M +106.8%
EPS	1.02 +108.2%
Shares Out	60.50M
PE Ratio	96.94
Forward PE	n/a
Dividend	0.15 (0.15%)
Ex-Dividend Date	Jul 11, 2025

Volume	1,407,277
Average Volume	1,001,904
Open	101.20
Previous Close	98.88
Day's Range	98.87 - 103.18
52-Week Range	59.15 - 118.68
Beta	0.95
RSI	46.45
Earnings Date	Apr 29, 2026

About Jenkem Technology

Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, multi-arm heterofunctional disubstituted, amino-polyglycolic, N-terminated polyethylene glycol-modified, and thiol-modified polyethylene glycol PEG pro...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 269
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688356

Financial Performance

In 2025, Jenkem Technology's revenue was 318.22 million, an increase of 40.13% compared to the previous year's 227.10 million. Earnings were 61.70 million, an increase of 106.78%.